A randomized, double-blind, cross-over protocol was conducted, entailing the administration of NAC (2g/day) for 60 days and then placebo for another 60 days (or vice versa)
Standard chemoradiation for glioblastoma results in progressive brain volume loss
GHK-Cu Dosing Protocol: Cycling, Frequency & Best Practices Introduction GHK-Cu dosing varies a lot depending on the form
While more robust human studies are needed, current research suggests it may become an important component of future healthy aging and longevity strategies
Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia
Parameters studied were feed consumption, body weight gain, fecal corticosteroids, locomotion and rearing